Lucid Diagnostics Inc expected to post a loss of 26 cents a share - Earnings Preview
08/03/2024 21:14
* Lucid Diagnostics Inc LUCD.OQ LUCD.O is expected
to show a
rise in quarterly revenue when it reports results on March 12
(estimated) for the period ending December 31 2023
* The New York City-based company is expected to report a
840.9% increase in revenue to $1.054 million from $112 thousand
a year ago, according to the mean estimate from 6 analysts,
based on LSEG data.
* LSEG's mean analyst estimate for Lucid Diagnostics Inc is
for a
loss of 26 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Lucid
Diagnostics
Inc is $3.40, above its last closing price of $1.27.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT ESTIMATE MET, SE %
E® MISSED
Sep. 30 2023 -0.27 -0.27 -0.34 Missed -24.8
Jun. 30 2023 -0.32 -0.32 -0.23 Beat 28.3
Mar. 31 2023 -0.34 -0.35 -0.40 Missed -14.7
Dec. 31 2022 -0.37 -0.38 -0.23 Beat 39.3
Sep. -0.42 -0.40 -0.39 Beat 1.7
30 2022
Jun. 30 2022 -0.36 -0.36 -0.41 Missed -14.2
Mar. 31 2022 -0.35 -0.33 -0.35 Missed -5.3
Dec. 31 2021 -0.20 -0.20 -0.32 Missed -58
This summary was machine generated March 8 at 21:14 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)